glp-1 medication craving management strategies Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) & dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, & can help control Beyond weight loss: Integrating GLP-1

Yang Y, Cui X, Chen Y, Wang Y, Li X, Lin L, Zhang H

Stratified by CPAP use Subgroup analysis stratified by CPAP use revealed that GLP-1 RAs significantly reduced AHI regardless of whether participants were on CPAP therapy

In this study, we also provided access to non-nutritive kaolin clay blocks and measured effects of both drugs on clay intake over 24 hours after a 7 day habituation period

December 27, 2024: FDA Posts Updates to Zepbounds Drug Label to Include More Information About Acute Pancreatitis Due to results from two clinical trials for Zepbound, the FDA has posted drug safety-related labeling changes for the weight-loss drug

Kia Mitchell: You also need to prepare for red flags

You have questions, we have answers